Cannabidiol: an anxiolytic or an antipsychotic new drug? (2011)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- Subjects: ESQUIZOFRENIA; INTERAÇÃO SOCIAL (COMPORTAMENTO SOCIAL); CANNABIS
- Language: Inglês
- Imprenta:
- Source:
- Título: Programa
- Conference titles: Reunião Anual da Federação de Sociedades de Biologia Experimental (FeSBE)
-
ABNT
PERES, F. F. et al. Cannabidiol: an anxiolytic or an antipsychotic new drug? 2011, Anais.. São Paulo: FeSBE, 2011. . Acesso em: 03 out. 2024. -
APA
Peres, F. F., Almeida, V., Levin, R., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., et al. (2011). Cannabidiol: an anxiolytic or an antipsychotic new drug? In Programa. São Paulo: FeSBE. -
NLM
Peres FF, Almeida V, Levin R, Zuardi AW, Hallak JEC, Crippa JA de S, Niigaki ST, Abílio VC. Cannabidiol: an anxiolytic or an antipsychotic new drug? Programa. 2011 ;[citado 2024 out. 03 ] -
Vancouver
Peres FF, Almeida V, Levin R, Zuardi AW, Hallak JEC, Crippa JA de S, Niigaki ST, Abílio VC. Cannabidiol: an anxiolytic or an antipsychotic new drug? Programa. 2011 ;[citado 2024 out. 03 ] - Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
- Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: reversal by cannabidiol
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
